Advisor Perspectives welcomes guest contributions. The views presented here do not necessarily represent those of Advisor Perspectives. My investment management firm’s portfolio has a large position in the health care sector, and with AbbVie’s $63 billion takeover bid for Allergan earlier this week, it’s timely to review why we bought into this sector. Without commenting on Allergan shares of which we own, or AbbVie which we do not, health care companies in general are noncyclical – health care consumption is stable and independent of the whims of the global economy.